866-997-4948(US-Canada Toll Free)

Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Published By :

Future Market Insights

Published Date : Jan 2019

Category :

Healthcare

No. of Pages : 221 Pages

A recent market study published by the company – 'Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028', consists of an inclusive assessment of the most important market dynamics on Cytomegalovirus with assessed medications. The company has done some direct research on the principle structure of the Cytomegalovirus treatment market. A direct market overview provides the growth scenarios and market potential with maximum precision, and adjudged with suitable assumptions. The report features unique and relevant factors that may have a huge impact on the development of the Cytomegalovirus treatment market during the forecast period. This report includes a detailed and considerable amount of inclusion, which would help new manufacturers with the most comprehensive way for better understanding

Chapter 1 – Executive Summary

The report commences with the executive summary of the Cytomegalovirus treatment market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) for leading segments in the Cytomegalovirus treatment market.

Chapter 2 – Market Introduction

Readers can find a detailed market structure and definition of Cytomegalovirus treatment and drug types, in this chapter, which helps in understanding the basic information about the Cytomegalovirus treatment market. The definition section considers the factors included and excluded for the purpose of this report.

Chapter 3 – Market Background

Readers can find the outlook of the global Cytomegalovirus treatment market, considering various factors associated with the growth, which would help in tracking the market’s current scenario, with key inferences drawn from historical data, current trends, and future prospects. Macro-economic factors influencing the market are also discussed in this segment. A brief understanding of the global healthcare sector is also provided in this section.

Chapter 4 – Market Dynamics

This chapter highlights the key market dynamics, including drivers, restraints, opportunities, and trends. In this chapter, readers can understand factors that are propelling the growth of the market, along with factors that may deter the growth of the market. Also, readers will understand the key trends followed by leading manufacturers in the Cytomegalovirus treatment market.

Chapter 5 – Cytomegalovirus Treatment Market: Key Inclusions

Key pointers such as pipeline drug analysis, reimbursement scenarios and new medical treatments for Cytomegalovirus are also included in this Cytomegalovirus treatment market report.

Chapter 6 – North America Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth being observed in the North America Cytomegalovirus treatment market, along with country-wise assessment for the U.S. and Canada. Readers can also find information on regional trends, regulations and market growth based on Drug type, Application and Distribution channel and countries in North America.

Chapter 7 – Western Europe Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

Important growth prospects of the Cytomegalovirus treatment market can be found with market attractiveness based on Drug type, Application and Distribution channel. European countries such as the U.K., Germany, France, Italy, Spain, Russia and Rest of Western Europe are included in this chapter for industry analysis.

Chapter 8 – Eastern Europe Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the Eastern Europe Cytomegalovirus treatment market, along with a country-wise assessment, including Russia, Poland and Rest of Eastern Europe. Market attractiveness based on various segments is provided for the Eastern European region.

Chapter 9 – Latin America Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the Latin America Cytomegalovirus treatment market, along with a country-wise assessment, including Brazil, Mexico and Rest of Latin America. Market attractiveness based on various segments is provided for the Latin American region

Chapter 10 – APEC Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

India, Australia & New Zealand, Japan and Rest of APAC are the leading countries/regions in the Asia Pacific region that are assessed to obtain the growth prospects of the APEC Cytomegalovirus treatment market in this chapter. Readers can find thorough information about the growth parameters. Market attractiveness based drug type, Application, and distribution channel for Cytomegalovirus treatment in the APEC region is also provided in this section.

Chapter 11 – China Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the China Cytomegalovirus treatment market. Market attractiveness based drug type, Application, and distribution channel is present for this region

Chapter 12 – MEA Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter provides information on how the Cytomegalovirus treatment market will grow in major countries of the MEA region, such as Saudi Africa, GCC Countries and Rest of MEA, during the period 2018-2028.

Chapter 13 – Forecast Factors: Relevance and Impact

This chapter provides forecast factors for relevance in building the market value for the Cytomegalovirus treatment market

Chapter 14 – Competitive Assessment

This chapter includes a comprehensive list of all the leading manufacturers in the Cytomegalovirus treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, and recent company developments. Market players featured in the report include Merck & Co. Inc, Mylan N.V., Chimerix, Inc., Thermo Fisher Scientific, Abbott, Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pfizer and among others

Chapter 15 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Region

This section highlights Cytomegalovirus treatment in the overall global market by value (US$ Mn) forecast and analysis, by region such as North America, Latin America, Western Europe, Eastern Europe and Asia Pacific Including Japan, China and MEA.

Chapter 16 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Drug Type

Based on drug type market analysis, the Cytomegalovirus treatment market is segmented into Ganciclovir, valganciclovir, Foscarnet, Cidofovir and other.

Chapter 17 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Application

Based on Application, the Cytomegalovirus treatment market is segmented into Stem Cell Transplantation, Organ Transplantation, Congenital CMV infection and others.

Chapter 18 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Distribution Channel

Based on distribution channel, the Cytomegalovirus treatment market is segmented into hospital pharmacies, retail pharmacies, drugstores, and e-Commerce.

Chapter 19 – Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This section highlights the overall global market value (US$ Mn) forecast and analysis of the Cytomegalovirus treatment market, with detailed incremental opportunity and absolute opportunity.

Chapter 20 – Assumptions and Acronyms Used

This section consists of a glossary of the assumptions and acronyms used in the Cytomegalovirus treatment market report.

Chapter 21 – Research Methodology

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the Cytomegalovirus treatment market.

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition

3. Market Background
3.1. Market Overview
3.2. Macroeconomic Assumptions
3.3. Global Economic Outlook

4. Market Dynamics
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunity Analysis
4.1.4. Trends

5. Cytomegalovirus Treatment Market: Key Inclusions 
5.1. Pipeline Analysis 
5.2. Reimbursement Scenarios
5.3. Cytomegalovirus Treatment: Timeline  

6. North America Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2018–2028
6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
6.4.1. Ganciclovir
6.4.2. Valganciclovir
6.4.3. Foscarnet
6.4.4. Cidofovir
6.4.5. Others 
6.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
6.6.1. Stem Cell Transplantation
6.6.2. Organ Transplantation
6.6.3. Congenital CMV infection
6.6.4. Others 
6.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
6.8.1. Hospital pharmacies
6.8.2. Retail Pharmacies
6.8.3. E-commerce
6.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Drug Type
6.10.3. By Application
6.10.4. By Distribution Channel
6.11. Drivers and Restraints – Impact Analysis

7. Western Europe Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) By Country, 2013–2017
7.2.1. Germany
7.2.2. France
7.2.3. U.K.
7.2.4. Spain
7.2.5. Italy
7.2.6. Rest of Western Europe
7.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2018–2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
7.4.1. Ganciclovir
7.4.2. Valganciclovir
7.4.3. Foscarnet
7.4.4. Cidofovir
7.4.5. Others 
7.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
7.6.1. Stem Cell Transplantation
7.6.2. Organ Transplantation
7.6.3. Congenital CMV infection
7.6.4. Others 
7.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.8.1. Hospital pharmacies
7.8.2. Retail Pharmacies
7.8.3. E-commerce
7.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Drug Type
7.10.3. By Application
7.10.4. By Distribution Channel
7.11. Drivers and Restraints – Impact Analysis

8. Eastern Europe Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) By Country, 2013–2017
8.2.1. Russia
8.2.2. Poland
8.2.3. Rest of Eastern Europe
8.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2018–2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
8.4.1. Ganciclovir
8.4.2. Valganciclovir
8.4.3. Foscarnet
8.4.4. Cidofovir
8.4.5. Others 
8.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
8.6.1. Stem Cell Transplantation
8.6.2. Organ Transplantation
8.6.3. Congenital CMV infection
8.6.4. Others 
8.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.8.1. Hospital pharmacies
8.8.2. Retail Pharmacies
8.8.3. E-commerce
8.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Drug Type
8.10.3. By Application
8.10.4. By Distribution Channel
8.11. Drivers and Restraints – Impact Analysis

9. Latin America Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) By Country, 2013–2017
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2018–2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
9.4.1. Ganciclovir
9.4.2. Valganciclovir
9.4.3. Foscarnet
9.4.4. Cidofovir
9.4.5. Others 
9.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
9.6.1. Stem Cell Transplantation
9.6.2. Organ Transplantation
9.6.3. Congenital CMV infection
9.6.4. Others 
9.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.8.1. Hospital pharmacies
9.8.2. Retail Pharmacies
9.8.3. E-commerce
9.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Drug Type
9.10.3. By Application
9.10.4. By Distribution Channel
9.11. Drivers and Restraints – Impact Analysis

10. Asia Pacific excluding China (APEC) Cytomegalovirus Treatment Market   Analysis 2013–2017 and Opportunity Assessment 2018–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) By Country, 2013–2017
10.2.1. India
10.2.2. Australia and New Zealand
10.2.3. Japan
10.2.4. Rest of APEJ
10.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2018–2028
10.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
10.4.1. Ganciclovir
10.4.2. Valganciclovir
10.4.3. Foscarnet
10.4.4. Cidofovir
10.4.5. Others 
10.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
10.6.1. Stem Cell Transplantation
10.6.2. Organ Transplantation
10.6.3. Congenital CMV infection
10.6.4. Others 
10.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
10.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.8.1. Hospital pharmacies
10.8.2. Retail Pharmacies
10.8.3. E-commerce
10.9.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Drug Type
10.10.3. By Application
10.10.4. By Distribution Channel
10.11. Drivers and Restraints – Impact Analysis

11. China Cytomegalovirus Treatment Market  Analysis 2013–2017 and Opportunity Assessment 2018–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
11.2.1. Ganciclovir
11.2.2. Valganciclovir
11.2.3. Foscarnet
11.2.4. Cidofovir
11.2.5. Others 
11.3. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
11.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
11.4.1. Stem Cell Transplantation
11.4.2. Organ Transplantation
11.4.3. Congenital CMV infection
11.4.4. Others 
11.5. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.6.1. Hospital pharmacies
11.6.2. Retail Pharmacies
11.6.3. E-commerce
11.7.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
11.8. Market Attractiveness Analysis
11.8.1. By Drug Type
11.8.2. By Application
11.8.3. By Distribution Channel
11.9. Drivers and Restraints – Impact Analysis

12. MEA Cytomegalovirus Treatment Market   Analysis 2013–2017 and Opportunity Assessment 2018–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) By Country, 2013–2017
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of MEA
12.3. Market Size (US$ Mn) Opportunity Assessment By Country, 2018–2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
12.4.1. Ganciclovir
12.4.2. Valganciclovir
12.4.3. Foscarnet
12.4.4. Cidofovir
12.4.5. Others 
12.5. Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
12.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
12.6.1. Stem Cell Transplantation
12.6.2. Organ Transplantation
12.6.3. Congenital CMV infection
12.6.4. Others 
12.7. Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
12.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.8.1. Hospital pharmacies
12.8.2. Retail Pharmacies
12.8.3. E-commerce
12.9. Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Drug Type
12.10.3. By Application
12.10.4. By Distribution Channel
12.11. Drivers and Restraints – Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Competition Analysis

14.1. Competition Dashboard
14.2. Company Deep Dive
14.2.1. Merck & Co. Inc.,
14.2.1.1. Overview
14.2.1.2. Product and Application Portfolio
14.2.1.3. Analyst Commentary 
14.2.1.4. Strategy
14.2.1.4.1. Marketing Strategy
14.2.1.4.2. Product Strategy
14.2.1.4.3. Channel Strategy
14.2.2. Mylan N.V.
14.2.3. Chimerix, Inc., 
14.2.4. Thermo Fisher Scientific
14.2.5. Abbott
14.2.6. Becton, Dickinson and Company, 
14.2.7. Johnson & Johnson, 
14.2.8. Bio-Rad Laboratories, Inc.,
14.2.9. F. Hoffmann-La Roche Ltd
14.2.10. Pfizer 

15. Global Cytomegalovirus Treatment Market  Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Region
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017 
15.2.1. North America
15.2.2. Western Europe
15.2.3. Eastern Europe
15.2.4. Latin America
15.2.5. Asia Pacific excluding China
15.2.6. China
15.2.7. Middle East and Africa
15.3. Market Size (US$ Mn) Opportunity Assessment By Region, 2018–2028
15.4. Market Attractiveness Analysis By Region

16. Global Cytomegalovirus Treatment Market  Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Type, 2013–2017
16.2.1. Ganciclovir
16.2.2. Valganciclovir
16.2.3. Foscarnet
16.2.4. Cidofovir
16.2.5. Others 
16.3.  Market Size (US$ Mn) Opportunity Assessment By Drug Type, 2018–2028
16.4. Market Attractiveness Analysis By Drug Type

17. Global Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Application
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
17.2.1. Stem Cell Transplantation
17.2.2. Organ Transplantation
17.2.3. Congenital CMV infection
17.2.4. Others
17.3.  Market Size (US$ Mn) Opportunity Assessment By Application, 2018–2028
17.4. Market Attractiveness Analysis By Application

18. Global Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel 
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
18.2.1. Hospital pharmacies
18.2.2. Retail Pharmacies
18.2.3. E-commerce
18.3.  Market Size (US$ Mn) Opportunity Assessment By Distribution Channel, 2018–2028
18.4. Market Attractiveness Analysis By Distribution Channel

19. Global Cytomegalovirus Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028
19.1. Market Value Share Analysis 
19.1.1. By Country
19.1.2. By Drug Type
19.1.3. By Application
19.1.4. By Distribution Channel
19.2. Y-o-Y Growth Analysis
19.2.1. By Country
19.2.2. By Drug Type
19.2.3. By Application
19.2.4. By Distribution Channel
19.3. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *